Dr. Jewa Maria Lea, DC Chiropractor - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 15202 Dino Dr, Burtonsville, MD 20866 Phone: 301-421-1420 Fax: 301-421-1426 |
Burtonsville Chiropractic And Rehab Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 15202 Dino Dr, Burtonsville, MD 20866 Phone: 301-421-1420 Fax: 301-421-1426 |
Block Wellness, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 3901 National Dr Ste 250, Burtonsville, MD 20866 Phone: 301-476-7575 Fax: 301-476-7730 |
Dr. Maryjoyce Rotella, DC, LAC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 15891 Kruhm Rd, Burtonsville, MD 20866 Phone: 301-421-4248 |
Dr. Debra M Block, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 3919 National Dr, Suite 110, Burtonsville, MD 20866 Phone: 301-476-7575 Fax: 301-476-7730 |
Alexander Oni Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4219 Cedar Tree Ln, Burtonsville, MD 20866 Phone: 202-355-2317 |
News Archive
A rare and often underreported form of stroke that involves veins instead of arteries is more common than previously thought, according to the American Heart Association's first scientific statement on diagnosing and managing cerebral venous thrombosis (CVT).
Recent study published online by Melanoma Research journal indicates that melanoma patients would significantly benefit from prolonging the survival with oncolytic viroherapy treatment. The study revealed that the early stage melanoma patients treated with oncolytic medicine Rigvir were 4 to 6 times more likely to survive than those who following the current guidelines for the treatment of melanoma were only observed.
The major challenge for public health in the era of genomics is to generate the base of evidence necessary to demonstrate when use of genomic information in public health can improve health outcomes in a safe, effective and cost-effective manner, participants at an international meeting have concluded.
Researchers will meet at the Society of Toxicology's Annual Meeting and ToxExpo March 10-16 to discuss a number of health concerns that have received growing public attention over the past several months.
The U.S. Food and Drug Administration is notifying health care professionals of updated dosing recommendations for Valcyte (valganciclovir) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant.
› Verified 2 days ago